chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3:00 am woke up and vomited,  Continued to wake up with 3 bouts of diarrhea,  had chills & fever of 101,  slept in until 10:00,  got up and took 1st dose of ibuprofin,  felt achy and very lethargic all morning and afternoon, Continued to take doses of ibuprofin,  Fever came down and some achiness went away due to ibuprofin,  felt better by evening (24 hrs. after shot) but still had slight fever and still fatigued. By morning of 3/20 I felt much better.
blisters on my arm; itching all over; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (blisters on my arm) and PRURITUS (itching all over) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLISTER (blisters on my arm) and PRURITUS (itching all over). At the time of the report, BLISTER (blisters on my arm) and PRURITUS (itching all over) had not resolved.            No concomitant medications were reported.  Treatment information was not provided. On December 2021, after the booster dose patient experienced itching all over and blisters on arm.
Tested positive with home Antigen test on May 9, 2022.  Had moderate cold-like symptoms:  runny nose, sneezing, coughing, fever max over two days was 99.9F.   Treatment was entirely at home with isolation, masking,  and Paxlovid prescription, per phone visit with clinic doctor who's name escapes me.   Dr. is my primary care physician who was not contacted, but who can view my record.
12 minutes in experienced light headed/ dizzy. Nurse said BP was 80/68. Waited and was fine from that. The follow week was itchy all over body but mainly scalp and forearms, took antihistamines and was fine.
He got the flu shot and now gets the flu every year; Initial information was received on 09-Oct-2020 regarding an unsolicited valid non-serious social media case from a consumer via social media.  This case involves male patient who got flu every year (influenza), while he received vaccine INFLUENZA VACCINE.  The patient's medical history, medical treatment, vaccinations, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number and expiration date were not reported) via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu every year (influenza), unknown latency following the administration of INFLUENZA VACCINE.  Laboratory data was not reported.  It was not reported if the patient received any corrective treatment or not.  The outcome of the event was unknown.  There will be no information on the batch number for this case.
Soreness in arm (~48 hours); fatigue (~48 hours); slight fever and nausea day after injection.
Patient with history of COVID vaccination admitted to hospital with COVID detected PCR. Per physician discharge summary, "Patient with a history of paroxysmal atrial fibrillation on DILTIAZEM, APIXABAN had developed respiratory symptoms and was found to have a COVID 19 infection.  He became aware of a rapid heart rate and was found to have atrial fibrillation with rapid ventricular response.  He was placed on an AMIODARONE drip and converted to normal sinus rhythm.  He was not hypoxic or particularly symptomatic with the COVID infection."
Vocal quality change (weak, breathy) started 3 days following Moderna vaccination on 5/5/22.
My daughter was given the following vaccines on 07/10/01: (1) DTaP, Tripedia, (2) Influenza, (3) hepatitis B. All these vaccines continued "Thimerosal," the very next day after the vaccines were given, my daughter had seizures. I have a detailed contemporaneous medical record that explain in detail this vaccine injury and the medical expert linked the mercury in thimerosal vaccine or causing my daughter permanent injuries. My daughter had a serious vaccine reaction that cannot be overlooked. I was informed to contact you because you monitor the safety of licensed vaccines. The attached medical report clearly reflects that the adverse event occurring after vaccination was actually caused by the vaccination. On 07/11/01, the next day after pt received the vaccines, pt began having seizures and was admitted to hospital from 07/11/01 to 07/14/01 and treated by a neurologist. It was determined that pt was having seizures diagnosed as "infantile spasms," which continued until 9/25/01 and permanently injured pt. Pt is blind in both eyes and deaf in both ears and mentally retarded caused by the infantile spasms. Diagnosis: blind, deaf, mentally retarded, autism. The dangerous mercury levels combined in all vaccines given o pt on 07/10/01 caused pt's immediate seizures the next day on 07/11/01. Pt was experiencing a normal childhood development until 07/10 & 11/2001, such drastically changed after receiving the vaccines containing Thimerosal. Pt demonstrated autistic like symptoms (infantile spasms) after receiving the injections, such infantile spasms.
The vaccine was to prevent further outbreaks of shingles.  I have now had two outbreaks of shingles since the vaccine and Dr. suggested I let your department know of the failure with me of the vaccine.
Local rxn to PEDIARIX 2h after developed redness swelling about 2cm diameter, lasted 4 weeks gradually resolved.
Severe arm pain at injection site relieved w/ice, chills, severe stomach pain, severe headache relieved by EXCEDRIN.
I had a slight headache,  dizziness, and soreness  (at site of injection)  soon after the shot. The soreness went away however after a week I'm still feeling a little bit of a headache and dizziness.  I'm still able to function relatively fine. It's especially noticeable when I'm just sitting down. When I'm exercising I really don't notice it. It also tends to be worse in the evening.
pain in my eyes; swelling to eyes; Everytime the sun hot my eyes they blurr up; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (pain in my eyes), EYE SWELLING (swelling to eyes) and VISION BLURRED (Everytime the sun hot my eyes they blurr up) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EYE PAIN (pain in my eyes), EYE SWELLING (swelling to eyes) and VISION BLURRED (Everytime the sun hot my eyes they blurr up). At the time of the report, EYE PAIN (pain in my eyes), EYE SWELLING (swelling to eyes) and VISION BLURRED (Everytime the sun hot my eyes they blurr up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medications were provided by the reporter. No Treatment History was provided by the reporter.   Reporter did not allow further contact
Fever, chills, severe body aches, especially the back and buttock area, nausea and vomiting, headache
Patient complained of a headache initially, and then several minutes later, began to experience chest pressure following the first dose of the Pfizer BioNTech COVID-19 Vaccine.  She was taken to the emergency department for further evaluation.
I had coughing and low temperature fever of 98.2. My legs felt sore around the knee area.
The patient reported having arm soreness and swelling the night she received the vaccine (11/13/17). She came to the pharmacy the morning of 11/14/17 reporting these symptoms. The pharmacist examined her arm and only saw a small red spot in the right deltoid (in the area of the vaccine administration). A few hours later, the patient reported dizziness and weakness and she felt like she was going to pass out. A store employee called 911 and she was taken to the emergency room. The patient states that they did full blood work, EKG, and a CT and found nothing abnormal. On 11/15/17, when examined by the pharmacist, the patient's arm was red from the middle of her bicep down to her elbow.
Received a booster dose of the Moderna Covid 19 vaccine bivalent from a vial that was punctured for 28 Hours.; Received a booster dose of the Moderna Covid 19 vaccine bivalent from a vial that was punctured for 28 Hours.; No Adverse Event; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Received a booster dose of the Moderna Covid 19 vaccine bivalent from a vial that was punctured for 28 Hours.), PRODUCT CONTAINER ISSUE (Received a booster dose of the Moderna Covid 19 vaccine bivalent from a vial that was punctured for 28 Hours.) and NO ADVERSE EVENT (No Adverse Event) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Received a booster dose of the Moderna Covid 19 vaccine bivalent from a vial that was punctured for 28 Hours.), PRODUCT CONTAINER ISSUE (Received a booster dose of the Moderna Covid 19 vaccine bivalent from a vial that was punctured for 28 Hours.) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Received a booster dose of the Moderna Covid 19 vaccine bivalent from a vial that was punctured for 28 Hours.), PRODUCT CONTAINER ISSUE (Received a booster dose of the Moderna Covid 19 vaccine bivalent from a vial that was punctured for 28 Hours.) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Received a booster dose of the Moderna Covid 19 vaccine bivalent from a vial that was punctured for 28 Hours.) and PRODUCT CONTAINER ISSUE (Received a booster dose of the Moderna Covid 19 vaccine bivalent from a vial that was punctured for 28 Hours.).    No concomitant medications was reported.  Patient was administered with Moderna Bivalent booster dose. Vial size was reported as 2.5ml  No treatment medications was reported.
Immediate feeling of nausea and headache after receiving shot. Within 30 minutes those symptoms increased. By next morning on 4/2, symptoms were migraine headache, sensitivity to light and sound, full body aches, joint pain, decreased appetite, chest pain, shortness of breath, fatigue. The symptoms gradually decreased and then resolved over the next 5 days.
Patient reported feeling dizzy about 15 minutes after vaccination. He refused an ambulance and requested us to not call 911.  Pharmacy intern walked with him and his wife to the car and reported him being wobbly. Wife of patient took him to the emergency room , where he was given Benadryl and fluids. Doctor diagnosed adverse affect as a mild allergic reaction. Wife of patient called the pharmacy to tell us he is doing better after Benadryl and fluids.
Pt received KINRIX and PROQUAD 3/10/14 then presented in office visit 3/11/14 with vomiting, nausea, fever. Pt had previously received KINRIX and PROQUAD 6/11/13 with no reactions. ZOFRAN prescribed for nausea/vomiting.
PATIENT IS 16, MODERNA COVID 19 IS ONLY RECOMMENDED IN PATIENTS 18 AND OLDER
Information has been received from a physician concerning a male who was vaccinated subcutaneously with a second dose of with varicella virus vaccine live (Oka/Merck) (lot# 658299/1020U). Two or three days later he experienced "red, wheel like localized site reaction that was swollen warm to touch". No medical attention was sought. It was reported that this did not happen with the first dose, just the booster shot. On an unspecified date, the patient recovered. No product quality complaint was involved. Follow-up information was received from a company representative who indicated that there wasn't any additional information to provide regarding the advise experiences. The physician does not want to provide any additional information either. This one of several reports from the same reporter. No further information is available.
First dose on 4/17/2021 and the second dose today, 5/3/2021; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a female patient who received Herpes zoster (Shingrix) (batch number F93YS, expiry date 8th October 2022) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 3rd May 2021, the patient received the 2nd dose of Shingrix (intramuscular) .5 ml. On 3rd May 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: The case was reported by patient for herself. The age at vaccination was not reported. The patient received her 1st dose on 17th April 2021. The patient received 2nd dose of Shingrix shorter than recommended interval  which led shortening of vaccination schedule. The pharmacist did not have the patient's date of birth of birth (DOB). The reporter did not consent to follow up.
It was described as chest pain and I checked to see if there was any abnormal heart issues. They diagnosed it as costochondritis correlated to an asthma attack. I've not had many asthma scenarios that felt like that only 1, 6 months after the 2nd dose where my medications were not keeping up. But this one was correlated with the dose 1 and another correlated with booster shot (which was Moderna). It seems first dose with each miRNA vaccine seems to correlate with my symptoms.
One day following vaccination patient developed pain, bruising and a 4 cm area of erythema at the site of injection.  Patient also describe generalized achiness and muscle pain.  MD prescribed Cipro.
a dose of PROQUAD was administered with VARIVAX for 8 different patients; This spontaneous report was received from a pharmacy technician and refers to a patient of unknown age and gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 30-MAR-2022, the patient received varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, 1 dose, lot #U024221, expiration date: 04-AUG-2023, administered for prophylaxis (strength, and route of administration were not provided); and  measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) subcutaneous injection, 1 dose, lot #U028179, expiration date: 08-MAR-2023, administered for prophylaxis (strength, and route of administration were not provided) (overdose). It is unknown if any product confusion occurred, that may have contributed to the error. No further information provided. No product quality complaints.  This is one of eight reports received from the same reporter.; Sender's Comments:  US-009507513-2204USA004906:
Subsequent to receiving one dose of varicella virus vaccine live the pt developed breakthrough chickenpox that consisted of 100 lesions. The pts sister also developed chickenpox. Follow up information indicated that the pt broke out first with approximately 100 pox. The pts sibling broke out with approximately 200 pox two weeks later. The pt did not have any pain or itching, while her sister had a great deal of pain and itching. The pt recovered within 7-9 days.
9-29-13 in evening had a swollen and sore arm. On Mon. 9-30-13 in the AM there was a large bruise (quarter size) continued to swell and hurt. Went to urgent care on 10/2/13 temperature and BP were OK. Was given Cephalexin 500mg for 1 week. Continues to have nausea, but the redness and swelling are decreasing.
Complains of tenderness in left deltoid muscle and induration  - has not redness, swelling, rash.
1 of 4 pts who exp an inject site reaction # the DTP site noly, approx 6 hrs p/immun; reaction consisted of swelling, redness, hot to touch & myalgia; required/ER MD visit; treated w/Advil;
Severe body aches became apparent around the 13 hour mark, nasal congestion began around the 6 hour mark, low grade fever (102.1) began around the 9 hour mark
Patient was having shortness of breath, dizziness, and was feeling nauseous. RPH called on ambulance. RPH also called after 5 hours to check to see how she was feeling. Patient doing good.
Information has been received from a licensed practical nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On an unknown date in 2016 (reported as "between 01-MAR-2016 and 14-JUL-2016"), the patient was inadvertently vaccinated with a dose of improperly stored M-M-R II (lot# L037356, expiration date 28-SEP-2017, therapy type rHA, route not reported). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
no adverse effect; multiple patients were vaccinated with improperly stored VAQTA on multiple dates; This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 22-OCT-2019, the patient was vaccinated with improperly stored hepatitis a vaccine, inactivated(VAQTA) lot # R002086, expiry date 22-APR-2019 for prophylaxis.  No adverse event was reported. Previous temperature excursion was reported. Data logger was involved.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA000067:
Started around January 1st, 2022, little achy sore throat and couldn't stay awake. January 8th or 9th I started having chest pains, woke up during the night stuffed up and felt like I had been hit with a truck. Between the 12th-20th of January I had a lot of trouble breathing, facial numbness, coughing, slight fever and nosebleeds. January 20th re-tested with home test and still showed positive. Had telehealth appt with my doctor and she prescribed me an inhaler for breathing issues. Took another home test week to week and a half later and still showed faint positive. I still am having increased migraines, still experiencing COVID-19 toe and brain fog, fatigue, body aches and coughing. I have remained to have gastro problems.
slight headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (slight headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (slight headache). At the time of the report, HEADACHE (slight headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Dizzy; Nausea; Tired; Headache; arm got a little bit tender; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: EL3302, via an unspecified route of administration on 13Jan2021 at a SINGLE DOSE for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  On 13Jan2021 towards the end of the day, the patient's arm got a little bit tender. It was fine, a little bit tender but nothing to worry about. But today (14Jan2021), later in the morning the patient started getting dizzy and had some nausea, was tired and had headache. The outcome of events was unknown.    No follow-up attempts are possible. No further information is expected. Information on the lot/batch number has been obtained.
This spontaneous report was received from a Nurse refers to a 4 year old patient. On 20-MAR-2014, the patient was vaccinated with improperly stored  (Oka/Merck) VARIVAX Lot # H014074 (dose, route and frequency were not reported). The nurse reported that the on 24-OCT-2013, (Oka/Merck) VARIVAX was stored for -13.9 C for 8 hours. On 29-OCT-2013, the (Oka/Merck) VARIVAX was stored for -12.8 C for 4 hours. On 14-NOV-2013, the (Oka/Merck) VARIVAX was stored for -11.4 C for 1.5 hours. On 26-MAR-2014, the (Oka/Merck) VARIVAX was stored for -14.7 C for 1.5 hours. On 14-MAY-2014, the (Oka/Merck) VARIVAX was stored for -13.8 C for a total of 5 hours. Since the overall average for (Oka/Merck) VARIVAX was below -15 C, these cumulative excursions of -11.4C for 20 hours is supported. No adverse effect has been reported. No further information was provided. This case linked to the case 1405USA015833, 1405USA015834, 1405USA015835, 1405USA015836, 1405USA015837, 1405USA015838, 1405UA015839, 1405UA015841, 1405USA015842 and 1405USA008798 (same reporter link). Additional information has been requested.
since getting the shots I have had several hematomas, the worst of which is in my leg and is still swollen for nearly a month. I have never had a hemotoma prior to  the vaccine
This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's concurrent and historical conditions were not reported. On an unknown date, the patient was vaccinated with an improperly stored dose of ZOSTAVAX Lot # L036822, expiration date 24-DEC-2017) dose, route and anatomical location were not provided. No concomitant medications were reported. The ZOSTAVAX was stored at 0 C temperature for 8 hours, there was no previous temperature excursion. No adverse symptoms reported. No product quality complaint was involved. Additional information has been requested.